Ben Rhee

Ben Rhee is a seasoned executive with a robust background in the life sciences and biotechnology sectors. As the co-founder of Mitokinin, Ben played a pivotal role in guiding the company toward a successful $110M acquisition by AbbVie. Currently, Ben serves as a Principal at PwC, where they lead U.S. Pharma Strategy and drive enterprise-wide transformations while managing a significant global pipeline. Previously, as a Managing Director at Accenture, they achieved substantial revenue growth and spearheaded transformative initiatives, establishing a strong reputation for delivering results and mentoring future leaders.